{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:52:31Z","timestamp":1790315551255,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.vaccine.2022.02.016","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T08:10:34Z","timestamp":1644480634000},"page":"1741-1746","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Projecting the cost of introducing typhoid conjugate vaccine (TCV) in the national immunization program in Malawi using a standardized costing framework"],"prefix":"10.1016","volume":"40","author":[{"given":"Fr\u00e9d\u00e9ric","family":"Debellut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rouden","family":"Mkisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Masoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Chisema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Mwagomba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mphatso","family":"Mtenje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumbani","family":"Limani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donnie","family":"Mategula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boston","family":"Zimba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clint","family":"Pecenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.02.016_b0005","doi-asserted-by":"crossref","unstructured":"IHME. Global Burden of Disease (GBD) Study. The Lancet. 2020 Oct 17;396(10258):1129\u2013306. https:\/\/www.thelancet.com\/journals\/lancet\/issue\/vol396no10258\/PIIS0140-6736(20)X0042-0","DOI":"10.1016\/S0140-6736(20)32131-0"},{"issue":"10","key":"10.1016\/j.vaccine.2022.02.016_b0010","doi-asserted-by":"crossref","first-page":"e570","DOI":"10.1016\/S2214-109X(14)70301-8","article-title":"Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment","volume":"2","author":"Mogasale","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"3","key":"10.1016\/j.vaccine.2022.02.016_b0015","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1016\/S2214-109X(17)30022-0","article-title":"Incidence of invasive salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study","volume":"5","author":"Marks","year":"2017","journal-title":"Lancet Glob Health"},{"issue":"Supplement_6","key":"10.1016\/j.vaccine.2022.02.016_b0020","doi-asserted-by":"crossref","first-page":"S492","DOI":"10.1093\/cid\/ciz525","article-title":"A systematic review of typhoid fever occurrence in Africa","volume":"69","author":"Kim","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2022.02.016_b0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006779","article-title":"A systematic review of antimicrobial resistance in Salmonella enterica serovar Typhi, the etiological agent of typhoid","volume":"12","author":"Britto","year":"2018","journal-title":"PLOS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2022.02.016_b0030","unstructured":"World Health Organization. Typhoid vaccines: WHO position paper \u2013 March 2018. Weekly Epidemiological Record. 2018 Mar 30;93(13):153\u201372. Available from: https:\/\/www.who.int\/publications\/i\/item\/typhoid-vaccines-who-position-paper-march-2018"},{"key":"10.1016\/j.vaccine.2022.02.016_b0035","unstructured":"International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. VIEW-hub. www.view-hub.org [accessed 2 November 2021]."},{"key":"10.1016\/j.vaccine.2022.02.016_b0040","unstructured":"Gavi, The Vaccine Alliance. Product information for vaccines and cold chain equipment. Available from: https:\/\/www.gavi.org\/news\/document-library\/detailed-product-profiles [accessed 27 September 2021]."},{"issue":"6","key":"10.1016\/j.vaccine.2022.02.016_b0045","doi-asserted-by":"crossref","first-page":"e016283","DOI":"10.1136\/bmjopen-2017-016283","article-title":"The STRATAA study protocol: a programme to assess the burden of enteric fever in Bangladesh, Malawi and Nepal using prospective population census, passive surveillance, serological studies and healthcare utilisation surveys","volume":"7","author":"Darton","year":"2017","journal-title":"BMJ Open"},{"issue":"Supplement_2","key":"10.1016\/j.vaccine.2022.02.016_b0050","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1093\/cid\/ciy1103","article-title":"Typhoid vaccine acceleration consortium Malawi: a phase III, randomized, double-blind, controlled trial of the clinical efficacy of typhoid conjugate vaccine among children in Blantyre","volume":"68","author":"Meiring","year":"2019","journal-title":"Malawi. Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2022.02.016_b0055","doi-asserted-by":"crossref","first-page":"E0003748","DOI":"10.1371\/journal.pntd.0003748","article-title":"Rapid emergence of multidrug resistant, H58-lineage Salmonella Typhi in Blantyre, Malawi","volume":"9","author":"Feasey","year":"2015","journal-title":"PLOS Neg Trop Dis."},{"issue":"suppl 4","key":"10.1016\/j.vaccine.2022.02.016_b0060","doi-asserted-by":"crossref","first-page":"S363","DOI":"10.1093\/cid\/civ691","article-title":"Three epidemics of invasive multidrug-resistant Salmonella bloodstream infection in Blantyre, Malawi, 1998\u20132014","volume":"61","author":"Feasey","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2022.02.016_b0065","doi-asserted-by":"crossref","first-page":"E1688","DOI":"10.1016\/S2214-109X(21)00370-3","article-title":"Burden of enteric fever at three urban sites in Africa and Asia: a multicentre population-based study","volume":"9","author":"Meiring","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"10258","key":"10.1016\/j.vaccine.2022.02.016_b0070","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2022.02.016_b0075","unstructured":"Resch S, Menzies N, Portnoy A, Clarke-Deelder E, O\u2019Keeffe L, Suharlim C, et al. How to cost immunization programs: a practical guide on primary data collection and analysis. Cambridge, MA: Harvard T.H. Chan School of Public Health; 2020. Available from: immunizationeconomics.org\/"},{"key":"10.1016\/j.vaccine.2022.02.016_b0080","unstructured":"World Health Organization. Guidelines for estimating costs of introducing new vaccines into the national immunization system. Geneva, Switzerland; 2002. Available from: http:\/\/archives.who.int\/vaccines-documents\/DocsPDF02\/www665.pdf"},{"key":"10.1016\/j.vaccine.2022.02.016_b0085","unstructured":"Working Paper. Common approach for the costing and financing analyses of routine immunization and new vaccine introduction costs. NUVI. Bill & Melinda Gates Foundation. Seattle, USA; 2013. Available from: https:\/\/static1.squarespace.com\/static\/556deb8ee4b08a534b8360e7\/t\/55970258e4b03cf942da51ac\/1435959896232\/WEBSITE_Common+Approach.pdf"},{"key":"10.1016\/j.vaccine.2022.02.016_b0090","unstructured":"World Health Organization. WHO Cervical Cancer Prevention and Control Costing Tool (C4P). 2016. Available from: http:\/\/www.who.int\/immunization\/diseases\/hpv\/C4P_USER_GUIDE_V1.0.pdf [accessed 2 November 2021]."},{"issue":"10","key":"10.1016\/j.vaccine.2022.02.016_b0095","article-title":"A case study using the United Republic of Tanzania: costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing Tool","volume":"10","author":"Hutubessy","year":"2012","journal-title":"BMC Med"},{"issue":"10","key":"10.1016\/j.vaccine.2022.02.016_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182663","article-title":"Experiences of operational costs of HPV vaccine delivery strategies in Gavi-supported demonstration projects","volume":"12","author":"Botwright","year":"2017","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2022.02.016_b0105","unstructured":"World Health Organization. Flutool Plus. WHO Seasonal Influenza Immunization Costing Tool (SIICT). 2020. Available from: https:\/\/www.who.int\/publications\/i\/item\/flutool-plus [accessed 2 November 2021]."},{"issue":"12","key":"10.1016\/j.vaccine.2022.02.016_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190006","article-title":"Maternal influenza immunization in Malawi: Piloting a maternal influenza immunization program costing tool by examining a prospective program","volume":"12","author":"Pecenka","year":"2017","journal-title":"PLOS ONE"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2022.02.016_b0115","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1093\/cid\/ciaa597","article-title":"Decision Making and Implementation of the First Public Sector Introduction of Typhoid Conjugate Vaccine\u2014Navi Mumbai, India, 2018","volume":"71","author":"Date","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.02.016_b0120","unstructured":"Government of Malawi. Department of Public Service Management. Revision of salaries in the civil service. 2020."},{"key":"10.1016\/j.vaccine.2022.02.016_b0125","unstructured":"WHO UNICEF coverage estimates WHO World Health Organization: Immunization, Vaccines And Biologicals. Vaccine preventable diseases Vaccines monitoring system 2020 Global Summary Reference Time Series: MCV1. [accessed 2022 Jan 19]. https:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/timeseries\/tswucoveragedtp3.html"},{"key":"10.1016\/j.vaccine.2022.02.016_b0130","unstructured":"Population National Statistics Office, Malawi National Census 2018. Population projection for 2022."},{"key":"10.1016\/j.vaccine.2022.02.016_b0135","unstructured":"Gavi, The Vaccine Alliance. Co-financing Policy. Version 2.0. Available from: https:\/\/www.gavi.org\/news\/document-library\/gavi-co-financing-policy [accessed 9 September 2021]."},{"key":"10.1016\/j.vaccine.2022.02.016_b0140","unstructured":"Gavi, The Vaccine Alliance. Eligibility and Transition Policy. Version 3.0. Available from: https:\/\/www.gavi.org\/news\/document-library\/gavi-eligibility-and-transition-policy [accessed 9 September 2021]."},{"key":"10.1016\/j.vaccine.2022.02.016_b0145","unstructured":"Gavi, The Vaccine Alliance. Gavi vaccine funding guidelines. Available from: https:\/\/www.gavi.org\/sites\/default\/files\/support\/Vaccine_FundingGuidelines.pdf [accessed 27 September 2021]."},{"key":"10.1016\/j.vaccine.2022.02.016_b0150","unstructured":"Government of Malawi. EPI Comprehensive Multi-Year Plan, 2016 \u2013 2020. September 2015."},{"issue":"35","key":"10.1016\/j.vaccine.2022.02.016_b0155","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1016\/j.vaccine.2021.06.076","article-title":"Cost of vaccine delivery strategies in low- and middle-income countries during the COVID-19 pandemic","volume":"39","author":"Banks","year":"2021","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22001396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22001396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:09:25Z","timestamp":1759403365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22001396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0264410X22001396"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.02.016","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Projecting the cost of introducing typhoid conjugate vaccine (TCV) in the national immunization program in Malawi using a standardized costing framework","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}